MX380683B - Lisobactina para su uso en el tratamiento de la mastitis bovina. - Google Patents
Lisobactina para su uso en el tratamiento de la mastitis bovina.Info
- Publication number
- MX380683B MX380683B MX2018002020A MX2018002020A MX380683B MX 380683 B MX380683 B MX 380683B MX 2018002020 A MX2018002020 A MX 2018002020A MX 2018002020 A MX2018002020 A MX 2018002020A MX 380683 B MX380683 B MX 380683B
- Authority
- MX
- Mexico
- Prior art keywords
- lysobactin
- treatment
- bovine mastitis
- mastitis
- bovine
- Prior art date
Links
- 208000031462 Bovine Mastitis Diseases 0.000 title abstract 2
- KQMKBWMQSNKASI-AVSFGBOWSA-N lysobactin Chemical compound O1C(=O)[C@H](CO)NC(=O)[C@H]([C@H](O)C(N)=O)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)CC(C)C)[C@H]1C1=CC=CC=C1 KQMKBWMQSNKASI-AVSFGBOWSA-N 0.000 title abstract 2
- KQMKBWMQSNKASI-UHFFFAOYSA-N lysobactin Natural products O1C(=O)C(CO)NC(=O)C(C(O)C(N)=O)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(C(O)C(C)C)NC(=O)C(NC(=O)C(CC(C)C)NC(=O)C(N)CC(C)C)C1C1=CC=CC=C1 KQMKBWMQSNKASI-UHFFFAOYSA-N 0.000 title abstract 2
- 108010011530 lysobactin Proteins 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a lisobactina para su uso en el tratamiento de la mastitis bovina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15181209 | 2015-08-17 | ||
| PCT/EP2016/069380 WO2017029271A1 (en) | 2015-08-17 | 2016-08-16 | Lysobactin for use in the treatment of bovine mastitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018002020A MX2018002020A (es) | 2018-06-15 |
| MX380683B true MX380683B (es) | 2025-03-12 |
Family
ID=53871958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002020A MX380683B (es) | 2015-08-17 | 2016-08-16 | Lisobactina para su uso en el tratamiento de la mastitis bovina. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20180346518A1 (es) |
| EP (1) | EP3337494B1 (es) |
| JP (1) | JP6921805B2 (es) |
| KR (1) | KR102780115B1 (es) |
| CN (1) | CN107921088B (es) |
| AR (1) | AR105728A1 (es) |
| AU (1) | AU2016310221B2 (es) |
| CA (1) | CA2995648C (es) |
| CO (1) | CO2018001531A2 (es) |
| CR (1) | CR20180110A (es) |
| DK (1) | DK3337494T3 (es) |
| ES (1) | ES2788734T3 (es) |
| HR (1) | HRP20200427T1 (es) |
| HU (1) | HUE048864T2 (es) |
| IL (1) | IL257342A (es) |
| LT (1) | LT3337494T (es) |
| MX (1) | MX380683B (es) |
| PE (1) | PE20180574A1 (es) |
| PH (1) | PH12018500339A1 (es) |
| PL (1) | PL3337494T3 (es) |
| PT (1) | PT3337494T (es) |
| RU (1) | RU2741764C2 (es) |
| SI (1) | SI3337494T1 (es) |
| TW (1) | TW201717991A (es) |
| WO (1) | WO2017029271A1 (es) |
| ZA (1) | ZA201801788B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024501940A (ja) * | 2020-12-24 | 2024-01-17 | インターベット インターナショナル ベー． フェー． | オルトソマイシン抗菌化合物を用いる乳腺炎の治療方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1266247A (en) * | 1985-03-25 | 1990-02-27 | Adrienne A. Tymiak | Antibiotic prepared from lysobacter sp. sc 14,067 |
| JPH01132600A (ja) | 1987-11-17 | 1989-05-25 | Shionogi & Co Ltd | カタノシンａおよびｂならびにその製造法 |
| DE10320781A1 (de) * | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | Acylierte Nonadepsipeptide |
| DE102004051024A1 (de) | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Heterocyclyl-substituierte Nonadepsipeptide |
| DE102004051025A1 (de) * | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Substituierte Nonadepsipeptide |
| DE102004051023A1 (de) * | 2004-10-20 | 2006-05-04 | Bayer Healthcare Ag | Desoxo-Nonadepsipeptide |
| DE102004053409A1 (de) | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Verfahren zur gezielten Herstellung von Lysobactinfragmenten |
| DE102004053407A1 (de) * | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Acylierte Nonadepsipeptide II |
| DE102004053410A1 (de) | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Cyclische Nonadepsipeptidamide |
| DE102006003443A1 (de) | 2006-01-25 | 2007-07-26 | Aicuris Gmbh & Co. Kg | Asparagin-10-substituierte Nonadepsipeptide |
| DE102006018250A1 (de) | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Verfahren zum Herstellen von cyclischen Depsipeptiden |
| DE102006018080A1 (de) | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Lysobactinamide |
-
2016
- 2016-08-15 TW TW105125886A patent/TW201717991A/zh unknown
- 2016-08-16 CA CA2995648A patent/CA2995648C/en active Active
- 2016-08-16 PE PE2018000260A patent/PE20180574A1/es not_active Application Discontinuation
- 2016-08-16 WO PCT/EP2016/069380 patent/WO2017029271A1/en not_active Ceased
- 2016-08-16 AU AU2016310221A patent/AU2016310221B2/en active Active
- 2016-08-16 SI SI201630691T patent/SI3337494T1/sl unknown
- 2016-08-16 JP JP2018508195A patent/JP6921805B2/ja active Active
- 2016-08-16 DK DK16757590.1T patent/DK3337494T3/da active
- 2016-08-16 RU RU2018109421A patent/RU2741764C2/ru active
- 2016-08-16 EP EP16757590.1A patent/EP3337494B1/en active Active
- 2016-08-16 CR CR20180110A patent/CR20180110A/es unknown
- 2016-08-16 CN CN201680048075.4A patent/CN107921088B/zh active Active
- 2016-08-16 HR HRP20200427TT patent/HRP20200427T1/hr unknown
- 2016-08-16 MX MX2018002020A patent/MX380683B/es unknown
- 2016-08-16 HU HUE16757590A patent/HUE048864T2/hu unknown
- 2016-08-16 ES ES16757590T patent/ES2788734T3/es active Active
- 2016-08-16 PT PT167575901T patent/PT3337494T/pt unknown
- 2016-08-16 LT LTEP16757590.1T patent/LT3337494T/lt unknown
- 2016-08-16 US US15/752,936 patent/US20180346518A1/en not_active Abandoned
- 2016-08-16 KR KR1020187007351A patent/KR102780115B1/ko active Active
- 2016-08-16 PL PL16757590T patent/PL3337494T3/pl unknown
- 2016-08-17 AR ARP160102525A patent/AR105728A1/es unknown
-
2018
- 2018-02-04 IL IL257342A patent/IL257342A/en unknown
- 2018-02-14 PH PH12018500339A patent/PH12018500339A1/en unknown
- 2018-02-16 CO CONC2018/0001531A patent/CO2018001531A2/es unknown
- 2018-03-16 ZA ZA201801788A patent/ZA201801788B/en unknown
-
2022
- 2022-06-06 US US17/832,868 patent/US20230125394A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2018005610A (es) | Derivados de oxopiridina sustituidos | |
| BR112019006160A2 (pt) | composições e métodos para o tratamento das condições oftálmicas | |
| CL2016001871A1 (es) | Anticuerpos humanos para pd-1 | |
| CO2017005784A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| MX2018003491A (es) | Represores de htt y usos de estos. | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| EA201691594A1 (ru) | Циклопропиламины в качестве ингибиторов lsd1 | |
| MX2017007049A (es) | Anticuerpos anti-cd79b y métodos de uso. | |
| BR112017025003A2 (pt) | composições compreendendo cepas bacterianas | |
| MX2021008376A (es) | Cultivo, produccion, procesamiento y uso de cannabis de especialidad. | |
| MX375352B (es) | Reguladores de nrf2. | |
| CO2017007121A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| CL2018000597A1 (es) | Métodos para tratar enfermedades inflamatorias | |
| EA201691610A1 (ru) | Анти-jagged1 антитела и способы применения | |
| CL2017002719A1 (es) | Imidazopirazinonas como inhibidores de pde1 | |
| CL2016003074A1 (es) | Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer. | |
| MX395231B (es) | Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos. | |
| MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
| MX374385B (es) | Apilimod para uso en el tratamiento de melanoma. | |
| EA201791937A1 (ru) | Противовоспалительные полипептиды | |
| MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
| CO2017010621A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. |